Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04589650 |
|---|---|
| Brief Title: | Study Assessing the Efficacy, Safety and PK of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (EPIK-P2) |
| First Submitted : | October 14, 2020 |
| First Submitted that Met QC Criteria : | October 14, 2020 |
| First Posted : | October 19, 2020 |
| Last Update Submitted that Met QC Criteria : | February 27, 2024 |
| Last Update Posted : | February 28, 2024 |